|
The following stocks are the leading risers and fallers on AIM on Friday. ---------- AIM - WINNERS ---------- RentGuarantor Holdings PLC, up 2.5% at 29.5 pence, 12-month range 12.75p-37.5p. The London-based rent guarantee services provider issues celebrity barrister and broadcaster Rob Rinder with 348,485 warrants to subscribe for new ordinary shares at an exercise price of 33p each, and says he has agreed to an orderly market provision for 24 months from Thursday in relation to any new shares issued to him through the warrant exercises. Investment forms part of the extension of RentGuarantor’s existing partnership with Rinder, which includes the expansion of Rinder’s role of brand ambassador. ‘With over 5.4 million households privately renting in the UK - and rising - RentGuarantor anticipates that demand for its service will expand, underpinned by the regulatory changes from the Renters’ Rights Act, due to commence implementation from [May 1],’ the company adds. Says the partnership with Rinder ‘will continue to form a significant part’ of its ‘mission’ to raise awareness of its services among potential customers. ---------- AIM - LOSERS ---------- Pulsar Helium Inc, down 12% at 82.75p, 12-month range 22p-101p. The US and Greenland-focused helium company raises gross proceeds of approximately £7.4 million through the issue of 9.2 million placing shares at 80p each. Says it will use the net proceeds to advance its flagship Topaz helium project in Minnesota, progress the Falcon Project in Michigan, and for general working capital. Plans at Topaz to conduct extended well testing and reservoir evaluation, and an additional seismic survey to enhance structural interpretation and reservoir modelling; to consolidate and expand its mineral and leasehold interests; to update the independent resource estimate; and to complete a pre-feasibility study for integrated helium and carbon dioxide production. Pulsar announced the placing on Thursday. ---------- SkinBioTherapeutics PLC, down 8.7% at 5.25p, 12-month range 5.25p-26.1p. The Newcastle Upon Tyne, England-based life science company appoints new Non-Executive Director Alyson Levett to oversee its continuing investigation process on behalf of the board. Says it has also appointed FRP Advisory to undertake an independent, forensic review into its now-former chief executive’s alleged misconduct. SkinBioTherapeutics on Monday said it was conducting an investigation following the resignation of former chief executive Stuart Ashman, over allegations that he misrepresented material information relating to accrued royalty income for financial 2025. ---------- Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
